Tuesday, October 4, 2011

Who are selling Geron under $2

Only the Scaredy-Cats, who have no business investing. Geron has a cash position of about $1.60 per share and a IP portfolio that has a potential value in the 100's of billions of dollars. If only one of the four platforms work out, the Longs will be very rich. The four platforms are GRNOPC1, GRN163L, GRN1005 and the drug toxicity platform. This is real, nothing has changed except for the management. "Chip" the new CEO is a big plus and will be making deals that will bring cash to Geron. Do your own research there is serious value here. The current price barely covers the cash on hand. If you are a True Believer like myself, buy a few more shares. I did at $1.95. We will be rewarded. A blockbuster is just around he corner. Always remember you can lose all your money in any stock.

Good luck in this rigged casino,

No comments:

Post a Comment